23andMe launches new genetic report on osteoporosis
Holding released a new polygenic risk score report on the genetics of osteoporosis for 23andMe+ Premium members. The report ...
telecareaware.com13h
23andMe running low on cash, considers sale, “strategic alternatives” by Special Committee
The latest unsurprising development in 23andMe’s story is the admission, by their new board of directors, that 23andMe now does not have enough cash to continue for the next 12 months. They are now ...